Replies to post #626 on Vascular Biogenics Ltd (VBLT)

[Oren1976]

Vbl should sell 2 billion per quarter once vb111 approved for ovarian and rgbm

[Prana1]

I am sorry. But where did you get this info about1) VB -111 being trialled alone
And 2) about the investigators given a choice to choose which pts continue in the trial based on fever?
Thanks.